InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: dr_c6 post# 81974

Tuesday, 12/24/2013 12:22:42 PM

Tuesday, December 24, 2013 12:22:42 PM

Post# of 403048
The company is currently at CFP on operations with existing products and with Isradipine dropping as their next drug launch.....which should get the company CFP on operations and R&D costs.....why in world would the company risk a RS prior to that? Makes absolutely no sense. The company will do best to put out their twice daily oxy/nal product and then look at matters regarding their share count six months down the road post twice daily launch IMO.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News